Prudential Financial
ATRA icon

Prudential Financial’s Atara Biotherapeutics ATRA Stock Holding History

Prudential Financial’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36,340
Closed -$309K – 2712
2024
Q2 		$309K Buy
+36,340
New +$546K ﹤0.01% 2342
2024
Q1 		– Sell
-1,074
Closed -$13.8K – 2672
2023
Q4 		$13.8K Buy
+1,074
New +$25K ﹤0.01% 2629
2022
Q4 		– Sell
-1,718
Closed -$162K – 2596
2022
Q3 		$162K Buy
+1,718
New +$193K ﹤0.01% 2476

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prudential Financial's ATRA Position: Q3 2024 in Review

Prudential Financial sold out of Atara Biotherapeutics (ATRA) in Q3 2024, closing a stake of 36,340 shares — an estimated $309K sold.

Prudential Financial first reported a position in ATRA in Q3 2022 and held it in 3 quarters. The position peaked at $309K in Q2 2024. 35 funds tracked by Wall St. Rank hold ATRA as of Q3 2024.

  • Prudential Financial reported no remaining Atara Biotherapeutics position as of Q3 2024 after selling out during the quarter.
  • Prudential Financial sold 36,340 Atara Biotherapeutics shares in Q3 2024, an estimated $309K.
  • Prudential Financial first reported a position in Atara Biotherapeutics in Q3 2022 and held it in 3 quarters.
  • Prudential Financial's Atara Biotherapeutics position peaked at $309K in Q2 2024.
  • 35 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2024.

Based on Prudential Financial's 13F filing for Q3 2024, filed 14 Nov 2024.